Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway

European Journal of Cancer

Volumn 49, Issue 15, 2013, Pages 3210-3218

  Lee, Sang Hyuk ^a   Nam, Hyo Jung ^a   Kang, Hyun Jung ^b   Kwon, Hye Won ^c   Lim, Young Chang ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Inha University School of Medicine   (South Korea)

Author keywords

Epigallocatechin 3 gallate; Head and neck cancer; Neoplastic stem cells; Notch; Therapy

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER C2; BREAST CANCER RESISTANCE PROTEIN; CISPLATIN; EPIGALLOCATECHIN GALLATE; HERMES ANTIGEN; NOTCH RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER STEM CELL; CHEMOSENSITIVITY; CONTROLLED STUDY; GENE; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOGRAFT;

EPIGALLOCATECHIN-3-GALLATE; HEAD AND NECK CANCER; NEOPLASTIC STEM CELLS; NOTCH; THERAPY;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOMA, SQUAMOUS CELL; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASTIC STEM CELLS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84884901283     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.06.025     Document Type: Article

References (33)

1. F. Kamangar, G.M. Dores, and W.F. Anderson Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2006 2137 2150
2. R.I. Haddad, and D.M. Shin Recent advances in head and neck cancer N Engl J Med 359 2008 1143 1154
3. D.G. Tang, L. Patrawala, and T. Calhoun Prostate cancer stem/progenitor cells: identification, characterization, and implications Mol Carcinog 46 2007 1 14
4. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111
5. M. Shackleton, E. Quintana, E.R. Fearon, and S.J. Morrison Heterogeneity in cancer: cancer stem cells versus clonal evolution Cell 138 2009 822 829
6. Y.C. Lim, S.Y. Oh, Y.Y. Cha, S.H. Kim, X. Jin, and H. Kim Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas Oral Oncol 47 2011 83 91
7. M. Dean, T. Fojo, and S. Bates Tumour stem cells and drug resistance Nat Rev Cancer 5 2005 275 284
8. L. Miele Notch signaling Clin Cancer Res 12 2006 1074 1079
9. L. Miele, H. Miao, and B.J. Nickoloff NOTCH signaling as a novel cancer therapeutic target Curr Cancer Drug Targets 6 2006 313 323
10. M. Katoh Notch signaling in gastrointestinal tract (review) Int J Oncol 30 2007 247 251
11. H. Korkaya, and M.S. Wicha HER-2, notch, and breast cancer stem cells: targeting an axis of evil Clin Cancer Res 15 2009 1845 1847
12. S. Masuda Dysfunctional transforming growth factor-beta signaling with constitutively active notch signaling in Barrett's esophageal adenocarcinoma Cancer 118 2012 1956 1957 [author reply 7-8]
13. H. Harrison, G. Farnie, and S.J. Howell Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor Cancer Res 70 2010 709 718
14. N. Stransky, A.M. Egloff, and A.D. Tward The mutational landscape of head and neck squamous cell carcinoma Science 333 2011 1157 1160
15. H.N. Graham Green tea composition, consumption, and polyphenol chemistry Prev Med 21 1992 334 350
16. G.Y. Yang, J. Liao, K. Kim, E.J. Yurkow, and C.S. Yang Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols Carcinogenesis 19 1998 611 616
17. Y.D. Jung, and L.M. Ellis Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea Int J Exp Pathol 82 2001 309 316
18. G.J. Du, Z. Zhang, and X.D. Wen Epigallocatechin gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea Nutrients 4 2012 1679 1691
19. S.U. Kang, B.S. Lee, S.H. Lee, S.J. Baek, Y.S. Shin, and C.H. Kim Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression J Nutr Biochem 24 2013 986 999
20. Y.W. Koh, E.C. Choi, and S.U. Kang Green tea (-)-epigallocatechin-3- gallate inhibits HGF-induced progression in oral cavity cancer through suppression of HGF/c-Met J Nutr Biochem 22 2011 1074 1083
21. Y.C. Lim, H.Y. Park, and H.S. Hwang (-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells Cancer Lett 271 2008 140 152
22. Y.C. Lim, H.J. Kang, Y.S. Kim, and E.C. Choi All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/beta-catenin pathway Eur J Cancer 48 2012 3310 3318
23. M.E. Prince, R. Sivanandan, and A. Kaczorowski Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proc Natl Acad Sci U S A 104 2007 973 978
24. S. Zhou, J.D. Schuetz, and K.D. Bunting The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype Nat Med 7 2001 1028 1034
25. K. Ohishi, N. Katayama, H. Shiku, B. Varnum-Finney, and I.D. Bernstein Notch signalling in hematopoiesis Semin Cell Dev Biol 14 2003 143 150
26. D. Chen, S. Pamu, Q. Cui, T.H. Chan, and Q.P. Dou Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells Bioorg Med Chem 20 2012 3031 3037
27. N. Nishimura, T.B. Hartomo, and T.V. Pham Epigallocatechin gallate inhibits sphere formation of neuroblastoma BE(2)-C cells Environ Health Prev Med 17 2012 246 251
28. S.N. Tang, J. Fu, D. Nall, M. Rodova, S. Shankar, and R.K. Srivastava Inhibition of sonic hedgehog pathway and pluripotency maintaining factors regulate human pancreatic cancer stem cell characteristics Int J Cancer 131 2012 30 40
29. W.W. Chang, F.W. Hu, and C.C. Yu Quercetin in elimination of tumour initiating stem-like and mesenchymal transformation property in head and neck cancer Head Neck 35 2013 413 419
30. B.B. Zhou, H. Zhang, M. Damelin, K.G. Geles, J.C. Grindley, and P.B. Dirks Tumour-initiating cells: challenges and opportunities for anticancer drug discovery Nat Rev Drug Discov 8 2009 806 823
31. N. Takebe, P.J. Harris, R.Q. Warren, and S.P. Ivy Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways Nat Rev Clin Oncol 8 2011 97 106
32. S. Liu, G. Dontu, and M.S. Wicha Mammary stem cells, self-renewal pathways, and carcinogenesis Breast Cancer Res 7 2005 86 95
33. A. Androutsellis-Theotokis, R.R. Leker, and F. Soldner Notch signalling regulates stem cell numbers in vitro and in vivo Nature 442 2006 823 826